Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation-Reference-Cited by-同舟云学术

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Published:2012-03 Issue:13 Volume:59 Page:1168-1174
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Lakkireddy Dhanunjaya,Reddy Yeruva Madhu,Di Biase Luigi,Vanga Subba Reddy,Santangeli Pasquale,Swarup Vijay,Pimentel Rhea,Mansour Moussa C.,D'Avila Andre,Sanchez Javier E.,Burkhardt J. David,Chalhoub Fadi,Mohanty Prasant,Coffey James,Shaik Naushad,Monir George,Reddy Vivek Y.,Ruskin Jeremy,Natale Andrea

Funder

Biosense Webster

St. Jude Medical

MC10

VOyage Medical

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up;Calkins;Europace,2007

2. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States;Naccarelli;Clin Cardiol,2010